Clinical trial
Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers
NCT03062163 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers
- Lead sponsor
- Chulalongkorn University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 23, 2017
- Completion date
- February 6, 2017
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lipolysis